During the past decade, The Third Hospital of Hebei Medical University conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 4 clinical trials were completed, i.e. on average, 7.5% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 1 clinical trials were completed. i.e. 3.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Third Hospital of Hebei Medical University" #1 sponsor was "Hebei Medical University Third Hospital" with 15 trials, followed by "Peking Union Medical College Hospital" with 4 trials sponsored, "Beijing Friendship Hospital" with 3 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 3 trials sponsored and "Sunshine Lake Pharma Co., Ltd." with 3 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Third Hospital of Hebei Medical University" #1 collaborator was "Hebei Medical University Third Hospital" with 7 trials as a collaborator, "Henan Provincial People's Hospital" with 4 trials as a collaborator, "Nanfang Hospital of Southern Medical University" with 4 trials as a collaborator, "The First Affiliated Hospital of Zhengzhou University" with 4 trials as a collaborator and "The First Hospital of Jilin University" with 4 trials as a collaborator. Other collaborators include 197 different institutions and companies that were collaborators in the rest 163 trials.

According to Clinical.Site data, the most researched conditions in "The Third Hospital of Hebei Medical University" are "Hepatitis B, Chronic" (4 trials), "Chronic HCV Infection" (3 trials), "Type 2 Diabetes" (3 trials), "Acute Ischemic Stroke" (2 trials) and "Chronic Hepatitis B" (2 trials). Many other conditions were trialed in "The Third Hospital of Hebei Medical University" in a lesser frequency.

Most popular intervention types in "The Third Hospital of Hebei Medical University" are "Drug" (37 trials), "Device" (9 trials), "Procedure" (7 trials), "Other" (4 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Adefovir" (2 trials), "Cyclophosphamide (CTX)" (2 trials), "DAG181" (2 trials) and "Entecavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Third Hospital of Hebei Medical University" are 65 trials for "All" genders.

Currently, there are NaN active trials in "The Third Hospital of Hebei Medical University". 1 are not yet recruiting, 14 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in The Third Hospital of Hebei Medical University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Third Hospital of Hebei Medical University, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 13 trials that are defined as “Not Applicable".

The Third Hospital of Hebei Medical University has several departments that took part in Clinical trials: "Department of General Surgery" - 2 trials